XML 44 R29.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Organization and Basis of Presentation (Tables)
 3 Months Ended
Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Components of Marketable Securities
As of March 31, 2024 and December 31, 2023, marketable securities consisted of the following ($ in thousands):
 March 31, 2024
 CostGross
Unrealized Gain (Loss)		Carrying Value
Equity securities:
Investment funds - debt securities$26,590 $(1,636)$24,954 
Common stock, preferred stock, and stock funds51,341 15,000 66,341 
Total - Marketable securities $77,931 $13,364 $91,295 

 December 31, 2023
 CostGross
Unrealized Gain (loss)		Carrying Value
Equity securities:
Investment funds - debt securities$26,460 $(1,584)$24,876 
Common stock, preferred stock, and stock funds51,328 11,591 62,919 
Total - Marketable securities $77,788 $10,007 $87,795 
Schedule of Changes in Accumulated Other Comprehensive Income, Net by Component
Changes in Accumulated Other Comprehensive Income, Net by Component

Essex Property Trust, Inc.
($ in thousands):
 Change in fair
value and amortization
of swap settlements
Balance at December 31, 2023$33,556 
Other comprehensive income before reclassification7,715 
Amounts reclassified from accumulated other comprehensive income 8 
Other comprehensive income7,723 
Balance at March 31, 2024$41,279 


Essex Portfolio, L.P.
($ in thousands):
 Change in fair
value and amortization
of swap settlements
Balance at December 31, 2023$38,646 
Other comprehensive income before reclassification7,986 
Amounts reclassified from accumulated other comprehensive income9 
Other comprehensive income7,995 
Balance at March 31, 2024$46,641 
Schedule of Changes to the Redemption Value of Noncontrolling Interests
The changes in the redemption value of redeemable noncontrolling interests for the three months ended March 31, 2024 is as follows ($ in thousands):
Balance at December 31, 2023$32,205 
Reclassification due to change in redemption value and other(13)
Balance at March 31, 2024$32,192 
Schedule of Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows ($ in thousands):
 March 31, 2024December 31, 2023March 31, 2023December 31, 2022
Cash and cash equivalents - unrestricted$499,036 $391,749 $67,712 $33,295 
Cash and cash equivalents - restricted8,834 8,585 9,446 9,386 
Total unrestricted and restricted cash and cash equivalents shown in the condensed consolidated statement of cash flows$507,870 $400,334 $77,158 $42,681 
Schedule of Restricted Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows ($ in thousands):
 March 31, 2024December 31, 2023March 31, 2023December 31, 2022
Cash and cash equivalents - unrestricted$499,036 $391,749 $67,712 $33,295 
Cash and cash equivalents - restricted8,834 8,585 9,446 9,386 
Total unrestricted and restricted cash and cash equivalents shown in the condensed consolidated statement of cash flows$507,870 $400,334 $77,158 $42,681